Genetic basis of phase II drug-metabolizing enzymes in antiepileptic drug toxicity

被引：0
|
作者：
不详
机构：
来源：
PHARMACOGENOMICS | 2012年 / 13卷 / 05期
关键词：
PHENYTOIN METABOLISM; CYP2C SUBFAMILY; POLYMORPHISMS; EPILEPSY; PHARMACOKINETICS; POPULATION; ABCB1;
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：521 / 522
页数：2
相关论文
共 50 条
  • [1] Update on the Genetic Polymorphisms of Drug-Metabolizing Enzymes in Antiepileptic Drug Therapy
    Saruwatari, Junji
    Ishitsu, Takateru
    Nakagawa, Kazuko
    PHARMACEUTICALS, 2010, 3 (08): : 2709 - 2732
  • [2] Cancer and phase II drug-metabolizing enzymes
    Sheweita, SA
    Tilmisany, AK
    CURRENT DRUG METABOLISM, 2003, 4 (01) : 45 - 58
  • [3] Genetic polymorphisms in drug-metabolizing enzymes and drug targets
    Hiratsuka, M
    Mizugaki, M
    MOLECULAR GENETICS AND METABOLISM, 2001, 73 (04) : 298 - 305
  • [4] The clinical role of genetic polymorphisms in drug-metabolizing enzymes
    D Tomalik-Scharte
    A Lazar
    U Fuhr
    J Kirchheiner
    The Pharmacogenomics Journal, 2008, 8 : 4 - 15
  • [5] CHLORPROMAZINE AND DRUG-METABOLIZING ENZYMES
    MOSTAFA, MH
    EVARTS, RP
    WEISBURGER, EK
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1979, (SEP): : 73 - 73
  • [6] Effects of genetic polymorphism of drug-metabolizing enzymes on the plasma concentrations of antiepileptic drugs in Chinese population
    Zhao, Weixuan
    Meng, Hongmei
    BIOENGINEERED, 2022, 13 (03) : 7709 - 7745
  • [7] Expression of drug-metabolizing enzymes
    Guengerich, FP
    Parikh, A
    CURRENT OPINION IN BIOTECHNOLOGY, 1997, 8 (05) : 623 - 628
  • [8] The clinical role of genetic polymorphisms in drug-metabolizing enzymes
    Tomalik-Scharte, D.
    Lazar, A.
    Fuhr, U.
    Kirchheiner, J.
    PHARMACOGENOMICS JOURNAL, 2008, 8 (01): : 4 - 15
  • [9] The ontogeny of human drug-metabolizing enzymes: Phase II conjugation enzymes and regulatory mechanisms
    McCarver, DG
    Hines, RN
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2002, 300 (02): : 361 - 366
  • [10] The Regulation of Diabetes Treatment Drug Glimepiride (GMP) towards Phase II Drug-Metabolizing Enzymes
    Li, Zhenjie
    Yue, Qingcai
    LATIN AMERICAN JOURNAL OF PHARMACY, 2016, 35 (02): : 379 - 382
12345